• Radiation Oncology Journal
• /
• 제12권3호
• /
• pp.369-376
• /
• 1994

This is a retrospective analysis of 64 patients who was treated with postoperative radiation therapy after radical hysterectomy and bilateral pelvic lymphadenectomy (53 patients) or total abdominal hysterectomy(11 patients) for uterine cervix cancer between May 1980 and September 1991 at the Department of Radiation Oncology, Kyung Hee University Hospital. Most patients were FIGO IB (31 Patients) and IIA (25 patients), and median period of follow-up was 5.1 years. Of these patients,24 received adjuvant whole pelvis irradiation of 6000 cGy and 40 received 5000-5500 cGy whole pelvis irradiation and/or intracavitary radiation (7 Patients). The actuarial overall and relapse free 5 year survival rate were $71.0\%$, $68.3\%$ respectively. The survival rates by stage were $79.1\%$ in stage I, and $61.2\%$ in stage II. Treatment failure was noted in 18 of 64 patients ($28.1\%$), Iocoregional failure in 8 ($12.5\%$), distant metastasis in 8 ($12.5\%$), paraaortic node metastasis in 1 and one patient and concurrent locoregional and distant metastasis. The univariate analysis of prognostic factors affecting to overall survival rate represented lymph node status, the number and site of metastatic lymph node, parametrial invasion, the thichness of cervical wall invasion, and size of cancer mass. Histology, vessel invasion, endometrial extension, hemoglobin level. resection margin status, age, radiation dose were not significant prognostic factors. Complication relating to operation and postoperative radiation were variable according to radiation therapy method: 6000 cGy RT group 8/24($33.3\%$), 5000-5500 cGy+ICR 3/7 ($42.9\%$), 5000-5500 cGy external RT only group 3/33 ($9.1\%$). In conclusion, the results suggest that postoperative radiotherapy is necessary in high risk patients for locoregional control and improving survival rate, and higher dose does not improve results but only increases complication.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권5호
• /
• pp.2279-2285
• /
• 2014

Background: To evaluate treatment outcomes of patients with stage I-III endometrial cancer treated with postoperative radiation. Materials and Methods: A retrospective review of 166 endometrial cancer patients, undergoing surgery and postoperative radiotherapy at Siriraj Hospital from 2005-2008 was performed. Pathology was reviewed. Results of treatment were reported with 5-year loco-regional recurrence free survival (LRRFS), 5-year overall survival (OS), patterns of failure and toxicity, and according to stage and risk groups. Results: Median follow up time was 62.8 months. Pathological changes were found in 36.3% of the patients after central reviews, leading to 19% changes in risk groups. Most of the patients (83.7%) received pelvic radiation (PRT) and vaginal brachytherapy (VBT). Five-year LRRFS and OS of all patients were 94.9% and 85.5%, respectively. There was no recurrence or death in low and low-intermediate risk groups. For the high-intermediate risk group, 5-year LRRFS and OS were 96.2% and 90.8%, respectively, and for the high risk group 90.5% and 71%. Late grade 3 and 5 gastrointestinal toxicity was found in 3% and 1.2% of patients, respectively. All of them received PRT 5,000 cGy in 25 fractions. Conclusions: Low and intermediate risk patients had good results with surgery and adjuvant radiation therapy. For high risk patients, postoperative radiation therapy alone appeared to be inadequate as the most common pattern of failure was distant metastasis.

• Investigative Magnetic Resonance Imaging
• /
• 제24권1호
• /
• pp.46-50
• /
• 2020

Radiation-induced lumbosacral plexopathy (RILSP) is an uncommon complication of pelvic radiotherapy that can result in different degrees of sensory and motor deficits. An age 59 female with cervical cancer, who had received combined chemotherapy and radiation therapy two years before, presented with bilaterally symmetric lower-extremity weakness and tingling sensation. The magnetic resonance imaging showed diffuse T2 bright signal intensity and mild enhancement along the bilateral lumbosacral plexus with no space-occupying masses. RILSP was diagnosed after the exclusion of malignant and inflammatory plexopathies.

• Radiation Oncology Journal
• /
• 제6권1호
• /
• pp.63-73
• /
• 1988

One hundred fifty-four patients with the carcinoma of the uterine cervix were studied retrospectively to assess the result and impact of treatment at Department of Radiation Oncology, Korea University, Hae-Wha Hospital from Feb 1981 through Dec. 1986. Prior to radiotherapy, the patients were evaluated and staged by recommendation of FIGO including physical examination, pelvic examination, cystoscopy, rectosigmoidoscopy, chest X-ray, IVP. Ba enema. Also, an additional pelvic CT scan was obtained for some of the patients. The patients were treated by radiotherapy alone or adjuvant postoperative irradiation; in case of radiation therapy only, whole pelvic irradiation was given with Co-60 teletherapy unit via AP and PA parallel opposing fields or 4-oblique fields, 180 cGy per day, 5 days per week and intracavitary insertion was performed. In satges Ia, Ib, and IIa with small primary lesion, external irradiation was initially given to pelvis up to $2,000\~3,000\;cGy/2frac{1}{2}\;-3frac{1}{2}$ weeks and then intracavitary insertion was performed using Fletcher-Mini-Declos Applicator with cesium-137 cources and followed by external irradiation of $1,000\~2,000\;cGy/1frac{1}{2}\;-2frac{1}{2}$weeks via AP and PA parallel opposing fields with midline shield to spare of bladder and rectum. However, if the primary lesion is large, external irradiation was given without midline shield. More than stages IIb, the patients were treated by external beam irradiation up to 5,400cGy/30f for 6 weeks via 4-oblique portals and at the dose of 5,040cGy/28f the field was cut 5cm from the top margin for spare of small bowel, and followed by intracavitary irradiation, If there was residual tumor an additional dose of $900\~l,200cGy/5\~7f$ was given to parametrium and/or residual tumor area. Total dose of radiation to A and B-point were as follows; A-point; In early stages, Ia, Ib, IIa; $8,000\~9,000$ B-point $5,000\~6,000 cGy$ A-point; In advanced stages IIb, IIIa, IIIb; $9,000\~10,000$ B-point $60,000\~7,000cGy$ The results were obtained and as fellows; 1 The patients distribution according to FIGO staging system were stage Ia 6, Ib 27, IIa 28, IIb 54, IIIa 12, IIIb 18, and stage IVa 9. 2. Value of CT scan were demonstration of cervix tumor mass, parametrial and pelvic side wall tumor spread, pelvic and inguinal lymph nodes metastases, and hydronephrosis. Three dimensional quantitative demonstration of tumor volume is also important in planning radiation therapy. Another advantage of CT scan was detection of recurrent tumor after radiation or surgery. 3. Local control rate of tumor according to the size was $91.3\%$ for less than 5cm in size and $44.6\%$ in tumor over 5cm (p<0.0068). 4. Thirty out of 50 recurrent sites has locoregional failures and 17 cases has distant metastases. And the para-aortic lymph nodes were the most common site for distant metastases. 5. The most common complication was temporal rectal bleeding which was controlled most by conservative management. However, 4 patients required for endoscopic cauterization. 6. The 5-year survival rates showed; stage la and Ib $95\%,\;stage\;IIa\;81\%\;stage\;lIb\;67\%,\;stage\;IIIa\;37.7\%,\;stage\;IIIb\;23\%$ and 3-year survival rate of stage IVa showed $11.6%$, retrospectively.

• Korean Journal of Radiology
• /
• 제1권4호
• /
• pp.198-207
• /
• 2000

Uterine cervical carcinoma is one of the most common malignant tumors occurring in females. After primary treatment, patients are usually followed up with CT or MRI and the findings of these modalities may be the first sign of recurrent disease. Because earlier additional treatment by chemotherapy or radiation therapy may improve the prognosis, the early detection of recurrent cervical carcinoma is clinically important. In this article, we review the CT and MR imaging findings of recurrent uterine cervical carcinoma, and assign them to one of four groups: a) recurrence at the primary site, involving the intrapelvic organs, b) extension to the pelvic side-wall, c) metastases to pelvic and extrapelvic lymph nodes, or d) metastases to distant organs. A further contribution of CT and MR imaging is the detection of hydronephrosis due to ureteral obstruction. The cases in each group are illustrated and discussed, and since an awareness of the spectrum of imaging findings of recurrent cervical carcinoma is likely to lead to its early detection, radiologists should be familiar with the information presented.

• 대한방사선치료학회지
• /
• 제3권1호
• /
• pp.11-18
• /
• 1989

Brachytherapy is known to be a good modality to achieve local control as a boost treatment following limited external irradiation, which may reduce the external beam related complication particularly in head and neck cancer. The authors developed iridium-192 ribbons recently to replace the radium needles in the field of brachytherapy. Total of 48 cases of head and neck and pelvic-perineal cancer patients had been treated with Ir-192 ribbons during last two years from October 1986 to September 1988, and the results were analyzed to assess the applicability of the fabricated sources. The conclusion is as follows; 1. Iridium implant resulted excellent tumor control effect in clinical application. 2. Iridium is superior than radium and cecium in brachytherapy because of easier to use and lesser exposure to the personnel. 3. Afterloading technique is useful to modify dose distribution, to expand treatment site and method, and to develop interstitial hyperthermia.

• 대한간호학회지
• /
• 제29권6호
• /
• pp.1179-1191
• /
• 1999

This study was conducted to identify appetite and nutritional status of 48 cancer patients who have been irradiated over 150$\textrm{cm}^2$ on chest or pelvic area over the three-month period. The data were gathered 3 phases, Each from initiation to completion of radiotherapy through the questionnaires of anorexia, the anthropometric and biochemical measures were used such as weight, TSF, MAC, MAMC, serum albumin and hemoglobin, TLC. Using SAS program, data were analyzed by percentage, Mean$\pm$SD, and two-way repeated measures ANOVA. The results were summarized as follows : 1. Eighty five percent(85%) of the subjects were aged from fifties to sixties. Cancers in the chest area occurred in 100% of men, 56% of the all subjects. The other 44% were pelvic cancer and 71% of the pelvic cancer occurred in women. 2. There were no significant differences in the appetite scores by all groups(characteristics). Changes of the appetite score over time were statistically significant by age, sex, cancer areas staging, treatment modality, and radiation dosage (F=4.0, p=.022; t=6.09, p=.003; t=4.90, p=.009; F=3.28, p=.042; t=5.04, p=.0084; t=4.76, p=.011). The appetite score on the 2nd phase (4 weeks after initiating radiotherapy) decreased from the 1st phase (initiating irradiation), and then increased on the 3rd phase (completing irradiation). 3. There were no significant differences in the body weight and MAMC by all characteristics, and no changes in the body weight and MAMC over time. However there were significant differences of TSF, MAC, level of hemoglobin, level of albumin, and TLC by all characteristics during the three phases. TSF of the men and the chest cancer were lower than those of the women and the pelvic cancer (t=73.20, p=.0001; t=22.91, p=.0001). And there was significant difference by cancer staging(F=3.19, p=.050). But there was no change in TSF over time. MAC of the men and the chest cancer were lower than those of the women and the pelvic cancer each(t=9.23, p=.004; t=17.85, p=.0001). But no change in MAC over time. Levels of hemoglobin had significant differences by age, sex and cancer areas; levels of hemoglobin of older than the fifties, men, and chest area were higher than those on the others(F=3.82, p=.029; t=21.75, p=.0001; t=8.71, p=.005). Levels of albumin were significant differences by sex and cancer areas; levels of albumin on women, and pelvic area were higher than those on the others(t=6.34, p=.015; t=15.23, p=.0003). While the levels of hemoglobin were changed over time, levels of albumin were not changed and within normal limit. TLC of the men was higher than women(t=5.05, p=.029). Changes in the level of hemoglobin over time were statistically significant according to sex, cancer areas, and radiation dosage(t=3.49, p=.035; t=3.36, p=.039; t=4.04, p=.021).

• 한국방사선학회논문지
• /
• 제3권3호
• /
• pp.5-11
• /
• 2009

영상유도방사선치료(image guided radiation therapy: IGRT) 시 환자를 1차적으로 skin marker를 이용하여 위치시키고 2차적으로 OBI(on board imager)를 이용하여 해부학적 위치를 확인 후 couch를 움직여 set up을 보정하게 되는데, 이때 발생하는 오차에 대한 평가를 하려고 한다. 치료계획시 $0^{\circ}$와 $270^{\circ}$방향의 DRR(digital reconstructed radiography) 영상과 OBI로 촬영한 영상을 2차원-2차원 정합(2D-2D matching)으로 비교하여 치료계획시 환자의 셋업과 치료시 환자의 셋업의 오차를 비교하였다. Head&Neck 및 Spinal cord와 같은 주요장기 부위의 치료에서는 치료때 마다 OBI에 의하여 셋업시 확인하였으며, Chest 및 Abdomen&Pelvic 는 일주일에 2~3회 확인하였다. 그려나 보정 값은 모두 OIS(oncology information system)에 기록하여 160명의 환자를 대상으로 각각 Head&Neck, Chest 및 Abdomen&Pelvic으로 나누어 피부 지표를 이용한 셋업의 정확성을 평가하였다. Head&Neck 환자의 평균 셋업 오차는 각각 AP, SI, RL 방향에서 $0.2{\pm}0.2cm$, $-0.1{\pm}0.1cm$, $-0.2{\pm}0.0cm$ 로 나타났으며, Chest의 경우 $-0.5{\pm}0.1cm$, $0.3{\pm}0.3cm$, $0.4{\pm}0.2cm$ 로 나타났고 Abdomen의 경우 $0.4{\pm}0.4cm$, $-0.5{\pm}0.1cm$, $-0.4{\pm}0.1cm$로 나타났다. Pelvic 의 경우 $0.5{\pm}0.3cm$, $0.8{\pm}0.4cm$, $-0.3{\pm}0.2cm$ 나타났다. Head&Neck 같은 강체 (rigid body)는 셋업 오차가 Chest 및 Abdomen 부위에 비하여 상대적으로 작게 나타났다. Chest에서는 횡축 방향의 오차가 컸으며, Abdomen&Pelvic 에서는 AP 방향의 오차가 크게 나타났다. Chest에서 횡축오차가 크게 나타난 이유는 환자 셋업시 환자 몸의 휘어짐에 기인한 것이며, Abdomen에서의 AP방향의 오차가 큰 이유는 환자의 호흡으로 인해 앞뒤 위치의 변화 때문으로 사료된다. 환자 셋업 시스템에서는 systematic error는 나타나지 않았다. OBI는 해부학적 위치를 확인하기 때문에 병소가 피부에 위치해 있을 경우 피부마커로 셋업을 하는 것이 정확할 것으로 생각된다. 2차원-2차원 정합은 3차원-3차원 정합과 비교하여 rolling 오차를 찾아내지 못하나 환자의 피폭이 적다는 장점이 있으며 셋업 확인 시간이 짧기 때문에 실제 임상에서는 2차원-2차원 정합이 유용하였다.

• Radiation Oncology Journal
• /
• 제16권1호
• /
• pp.63-69
• /
• 1998

목적 : 본 연구는 치료 선량의 방사선 조사역 내에 포함되는 소장의 용적을 전산화 단층 촬영을 통하여 측정함으로써 직장암의 수술 후 방사선치료 시 사용하는 소장 전위 장치의 효용성을 검토해보고자 하였다. 대상 및 방법 1997년 5월에 삼성서울병원 치료방사선과에서 방사선치료를 시작하게 된 10명의 직장암 환자들을 대상으로 하였다. 소장의 확인 및 구별을 용이하게 하기 위해 모의 치료 시작 전에 환자들에게 $Gastrographln^(R)$ 을 마시게 하였으며, 모의치료 시에는 환자들을 복와위로 엎드리게 하여 소장 전위 장치를 사용하지 않은 상태와 사용한 상태에서 방사선 조사역을 각각 결정하여 후전 및 측방 X-ray 영상을 얻었고, 같은 조건으로 전산화 단층 촬영을 각각 시행하였다. 전산화 단층 촬영 영상에서 조영제로 구별이 되는 소장 중에서 치료 선량의 방사선 조사역 내에 포함되는 소장의 용적을 영상 저장 및 전송 시스템(PACS) 을 이용하여 측정하였다. 결과 : 소장 전위 장치의 사용 전 및 사용 후의 측정된 소장의 평균 용적은 185.1ml(54.5-434.2ml) 및 176.0ml(5.2-415.6ml) 이었다. 소장 전위 장치의 사용 전과 비교한 사용 후의 소장 용적의 증감은 $10\%$ 이상 감소가 3명, $10\%$ 이하의 감소가 2명, $10\%$ 이하의 증가가 3명, $10\%$ 이상의 증가가 2명씩 이었다. 결론 : 직장암의 수술 후 방사선치료 시 사용하는 소장 전위 장치의 효용성을 소장 용적의 측정을 통하여 검토하여 본 결과 이 장치의 제작 및 사용에 소요되는 추가적인 시간과 노련을 감안하여 볼때 큰 이득이 없을 것으로 판단된다. 대한 반응이었으며, 병리학적 종류와 자궁 주변 침범의 정도는 경계의 의미가 있었다. 57명의 치료 실패가 있었으며 국소 재발은 2년 이내가 대부분 이었고 원격 전이는 3년 이후도 $29\%$를 보였다. 만성 합병증은 28명(16.8%) 38건에서 보였으며 발생률과 심한 정도가 총 선량과 1회당 선량에 유의한 상관관계가 있었다. 결론 : 국소적으로 진행된 자궁경부암은 종양의 크기와 치료에 대한 반응이 생존율과 국소재발에 가장 영향을 주는 요소이므로 방사선 치료를 할 때 종양의 크기에 따라 세분화하고 종양이 큰 경우 기존의 방법으로는 실패율이 비교적 높으므로 방사선 치료 기간의 단축이나 항암제의 추가 등을 고려하여 치료의 효과를 높여야 하며, 환자의 추적 관찰은 2년 이내 국소재발과 원격 전이가 많으므로 2년 이내는 적극적 추적 관찰의 중요성과 원격 전이의 경우 3년 이후 5년 이내에도 재발이 많기 때문에 종양표지자나 방사선학적 추적 관찰이 중요하다. 그리고 만성 합병증을 최소화하기 위해 적절한 질 packing 등으로 주위 조직의 방사선 피폭량을 줄여야 할 것으로 생각된다. 환자의 2년 생존을과 5년 생존율은 $29.9\%$와 $13.3\%$로 나타났으며, 병기가 낮고, 임상수행능력이 높을수록 생존율이 향상됨을 알 수 있었다. 또한 근치적 절제술후 방사선 치료를 받은 환자와 항암화학요법을 병행한 군의 치료성적이 비교적 높은 것으로 볼 때, 담낭 및 간외담도계 악성종양환자중 일부에서 적극적인 병합치료요법이 생존율의 향상에 도움을 줄 것으로 기대된다.술후 방사선치료 단독시행한 치료군보다 국소제어율을 높여주는 것을 알 수 있었으나($50.3\%\;vs.\;65.8\%,\;p=0.04$),

• Radiation Oncology Journal
• /
• 제16권4호
• /
• pp.497-504
• /
• 1998

목적 : matrix ion chamber type의 EPID와 video camera based EPID를 이용한 portal image와 기존의 film을 이용한 port film의 영상의 질을 객관적으로 비교 평가하여 EPID의 유용성을 알아보고자 본 연구를 계획하였다. 대상 및 방법 : 1997년 4월부터 10월까지의 인하대 병원과 세브란스 병원에서 방사선 치료를 받은 골반강내 치료 환자 각 10명씩을 대상으로 환자 1명 당 5-10회의 port film과 EPID를 이용한 portal image를 동시에 얻어 비교하였다. 환자의 나이는 32세에서 79세이었고 2명의 AP영상을 제외하고는 모두 PA영상을 얻었다. 환자의 두께는 17cm에서 20cm으로 비교적 균일하였다. beam energy는 10MV X-ray를 사용하였고 dose rate은 100-300MU/min으로 2-10MU을 주어 영상을 얻었다. port film은 Kodak diagnostic film을 사용하였고 film을 넣는 cassette는 납을 전후에 부착한 것을 이용하였다. source to detector(film) distance는 140cm으로 하였다. 영상의 판독은 4명의 치료방사선과 의사에 의해서 시행되었으며 pelvic brim, sacrum, acetabulum, iliopectineal line, symphysis, ischium, obturator foramen, sacroiliac joint를 각각 very clear(1), clear(2), visible(3), not clear(4), not visible(5) 다섯 단계로 나누어 점수를 주었다. 결과 : video camera based EPID를 이용하여 얻은 영상을 비교하여 보았을 때 film을 이용한 port film과 enhancement를 시행하지 않은 portal image는 각 해부학적 구조에서는 차이를 보이지 않았다. 그러나 portal image를 window level로 영상의 변화를 주었을 때는 sacrum과 obturator는 영상의 판독에 도움이 되었다. 또한 portal image를 CLAHE로 enhance를 하였을 때는 모든 해부학적 구조물의 판독이 film보다 용이한 것으로 나타났다. matrix ion chamber type의 EPID를 이용하여 얻은 영상에서도 역시 port film과 영상의 변화를 주지 않은 portal image간에는 커다란 차이를 보이지 않았으나, portal image를 window level로 변화를 주었을 경우는 portal film에 비하여 영상의 질이 더욱 좋아지을 알 수 있었다. 결론 : 방사선 치료를 받는 환자 중에서 골반강의 영상에서는 EPID의 영상의 질은 기존의 port film과 비교하여 차이가 없었으며, window level로 영상에 변화를 주거나 enhance를 하였을 경우는 port film보다 더 나은 영상을 얻을 수 있어 기존의 port film을 대체 할 수 있을 것으로 생각된다.